Highlights from ESMO 2025

About this episode

The episode discusses key updates from the 2025 ESMO Congress, focusing on recent clinical trial data.

This episode features recent updates presented at the 2025 European Society for Medical Oncology (ESMO) Congress in Berlin, Germany. Lisa Rauh-Benoit, MD, MPH, and Michelle Boisen, MD discuss data presented for trials including DUO-O, Rina-S/RAINFOL-1 , TV 205 and more, highlighting the key takeaways and implications for practice. View the accompanying PDF resource developed by the SGO Education Committee here (https://connected.sgo.org/content/highlights-esmo-2025).

People in this episode

Guests: Lisa Rauh-Benoit, MD, MPH, Michelle Boisen, MD

Topics covered

• oncology
• clinical trials
• medical updates
• ESMO Congress
• gynecologic oncology

Keywords

• ESMO 2025
• oncology trials
• clinical data
• gynecologic oncology
• medical practice implications

Mentioned in this episode

Organizations: European Society for Medical Oncology

Products: DUO-O, Rina-S/RAINFOL-1, TV 205

Places: Berlin, Germany